Reports for HYDROCHLOROTHIAZIDE

Ingredient

HYDROCHLOROTHIAZIDE

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
JAMP CANDESARTAN-HCT 16MG 12.5MG TABLET Resolved 2023-11-28 2024-05-25 211765
JAMP CANDESARTAN-HCT 12.5MG 16MG TABLET Resolved 2024-02-07 2024-05-25 218700
JAMP CANDESARTAN-HCT 12.5MG 32MG TABLET Resolved 2023-11-28 2024-05-25 211768
JAMP CANDESARTAN-HCT 12.5MG 32MG TABLET Resolved 2023-11-28 2024-05-25 211771
AA-AMILZIDE 5MG 50MG TABLET Anticipated shortage 2024-05-24 2024-05-24 228768
PMS-IRBESARTAN-HCTZ 25MG 300MG TABLET Resolved 2024-02-07 2024-05-24 218776
TEVA-TELMISARTAN HCTZ 25.0MG 80.0MG TABLET Actual shortage 2024-04-11 2024-05-23 224901
TEVA-IRBESARTAN HCTZ 300MG 25MG TABLET Actual shortage 2024-04-11 2024-05-23 224898
TEVA-IRBESARTAN HCTZ 300MG 12.5MG TABLET Actual shortage 2024-04-11 2024-05-23 224895
CANDESARTAN-HCTZ 12.5MG 16.0MG TABLET Resolved 2024-05-03 2024-05-16 227037

Showing 1 to 10 of 672

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-LISINOPRIL/HCTZ 12.5MG 10MG TABLET Discontinued 2017-03-13 2017-03-13 1093
APO-LISINOPRIL/HCTZ 12.5MG 20MG TABLET Discontinued 2017-03-13 2017-03-13 1090

Showing 101 to 102 of 102